"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted
Gene therapy company UniQure had another FDA meeting after Vinay Prasad's exit.
Ars Technica โ 17 June 2026
Text:
1
0
0
Gene therapy company UniQure had another FDA meeting after Vinay Prasad's exit.
This report comes from Ars Technica. The story centres on "Truly evil" FDA rejection of gene therapy overturned after Trump official ousted. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from Ars Technica and related outlets covering this beat.
Sources

